A higher risk of lipodystrophy has been associated with individual factors such as older age, and with drug related factors such as longer duration of antiretroviral treatment and associated metabolic disturbances.
Se ha relacionado un mayor riesgo de lipodistrofia con factores del individuo tales como edad avanzada y con factores relacionados con el fármaco tales como una larga duración del tratamiento antirretroviral y trastornos metabólicos asociados.